|
|||||
|
|
Peroxisome proliferator‐activated receptor γ agonist efatutazone impairs transforming growth factor β2‐induced motility of epidermal growth factor receptor tyrosine kinase inhibitor‐resistant lung cancer cells |
|
| Authors: | Masakuni Serizawa Haruyasu Murakami Masaru Watanabe Toshiaki Takahashi Nobuyuki Yamamoto Yasuhiro Koh |
| Affiliation: | 1. Drug Discovery and Development Division, Shizuoka Cancer Center Research Institute, , Shizuoka, Japan;2. Division of Thoracic Oncology, Shizuoka Cancer Center, , Shizuoka, Japan;3. Third Department of Internal Medicine, Wakayama Medical University, , Wakayama, Japan;4. +81‐73‐441‐0619+81‐73‐446‐2877 |
| Abstract: | |
| Keywords: | Efatutazone epidermal growth factor receptor‐tyrosine kinase inhibitor resistance motility non‐small cell lung cancer peroxisome proliferator‐activated receptor gamma |